Abstract
Obesity is a widespread condition associated with a variety of mechanical, metabolic, and physiologic changes that affect outcomes and delivery of care in ICU. In particular, the metabolic response to critical illness of obese patients is characterized by changes in the metabolism of carbohydrates and fat, and in the utilization of proteins. The endocrine functions of adipose tissue might be involved role in the adaptive changes to critical illness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132(6):2087–2102
Kuczmarski RJ, Flegal KM (2000) Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 72(5):1074–1081
Woods SC, D’Alessio DA (2008) Central control of body weight and appetite. J Clin Endocrinol Metab 93(11)(suppl 1):S37–S50
Chandra R, Liddle RA (2007) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14(1):63–67
Lorenz DN, Goldman SA (1982) Vagal mediation of the cholecystokinin satiety effect in rats. Physiol Behav 29(4):599
Wiedmer P, Nogueiras R, Broglio F, D’Alessio D, Tschop MH (2007) Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 3(10):705–712
Asakawa A, Inui A, Kaga T et al (2001) Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120(2):337–345
Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G (2010) GH/IGF-I regulation in obesity—mechanisms and practical consequences in children and adults. Horm Res Paediatr 73(3):153–160
Dube PE, Brubaker PL (2004) Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 36(11–12):755–760
Kinzig KP, D’Alessio DA, Seeley RJ (2002) The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 22(23):10470–10476
Hayes MR, De Jonghe BC, Kanoski SE (2010) Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav 100(5):503–510
Mafong DD, Henry RR (2008) Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction. Curr Atheroscler Rep 10(1):55–60
Hogue CW Jr, Stearns JD, Colantuoni E et al (2009) The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 35(7):1152–1170
Akinnusi ME, Pineda LA, El Solh AA (2008) Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 36(1):151–158
Oliveros H, Villamor E (2008) Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity (Silver Spring) 16(3):515–521
Cave MC, Hurt RT, Frazier TH et al (2008) Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract 23(1):16–34
Martino JL, Stapleton RD, Wang M et al (2011) Extreme obesity and outcomes in critically ill patients. Chest 140:1198–1206
Caloin M (2004) Modeling of lipid and protein depletion during total starvation. Am J Physiol Endocrinol Metab 287:E790–E798
Langouche L, Perre SV, Thiessen S et al (2010) Alterations in adipose tissue during critical illness: an adaptive and protective response? Am J Respir Crit Care Med 182:507–516
Winfield RD, Delano MJ, Dixon DJ et al (2010) Differences in outcome between obese and nonobese patients following severe blunt trauma are not consistent with an early inflammatory genomic response. Crit Care Med 38:51–58
Dunham CM, Fealk MH, Sever WE 3rd (2003) Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care 7:R145–R153
Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycemia. Lancet 373:1798–1807
Wolfe RR, Martini WZ (2000) Changes in intermediary metabolism in severe surgical illness. World J Surg 24:639–647
Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14–23
Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive medical therapy in the medical ICU. N Engl J Med 354:449–461
Jeevanandam M, Young DH, Schiller WR (1991) Obesity and the metabolic response to severe multiple trauma in man. J Clin Invest 87:262–269
Abdul-Ghani MA, Muller FL, DeFronzo RA et al (2008) Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 295:E678–E685
Schiffelers SL, Saris WH, van Baak MA (2001) The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men. Int J Obes Relat Metab Disord 25:33–38
Reid CL, Campbell IT, Little RA (2004) Muscle wasting and energy balance in critical illness. Clin Nutr 23:273–280
Choban PS, Flancbaum L (2000) Nourishing the obese patient. Clin Nutr 19(5):305–311
Dickerson RN, Boschert KJ, Kudsk KA (2002) Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition 18:241–246
Biolo G, Agostini F, Simunic B et al (2008) Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest. Am J Clin Nutr 88:950–958
Krishnan JA, PArce PB, Martinez A (2004) Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Nutr Clin Pract 19:645–646
Villet S, Chiolero RL, Bollmann MD et al (2005) Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 24:502–509
McClave SA, Martindale RG, Vanek VW et al (2009) Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33:277–316
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Coeffier, M., Tamion, F. (2016). The Stress Response of Critical Illness: Metabolic and Hormonal Aspects, Hormonal Regulation, Particular Clinical Situations “Morbid Obesity”. In: Preiser, JC. (eds) The Stress Response of Critical Illness: Metabolic and Hormonal Aspects. Springer, Cham. https://doi.org/10.1007/978-3-319-27687-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-27687-8_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27685-4
Online ISBN: 978-3-319-27687-8
eBook Packages: MedicineMedicine (R0)